
|Articles|October 27, 2020
- Vol 65 No 10
- Volume 65
- Issue 10
What did you think of this month’s cover story? October 2020
Let us know: Send us a message on Facebook, Twitter, or send an email to our editorial staff.
Advertisement
In the second installment of a 2-part Infertility series, ‘
Read Part 1 here:
Let us know: Send us a message on
Articles in this issue
about 6 years ago
Mental health support is critical during pandemicabout 6 years ago
Was this a failure to diagnose ovarian failure?about 6 years ago
Stand firm with scienceabout 6 years ago
Vulvar infection in patient with acute myeloid leukemiaabout 6 years ago
Choosing the right pillabout 6 years ago
Treatment of the infertile coupleabout 6 years ago
An imaging approach to early pregnancy failureabout 6 years ago
Age of anxietyabout 6 years ago
Test your knowledge of this rare vulvar conditionAdvertisement
Related to this article

Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.

Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.

In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.

HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
FDA approves pritelivir tablets to treat lesions from HSV
3
Anti-CGRP antibodies associated with higher spontaneous abortion risk
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5

